NASDAQ : VRTX

Vertex Pharmaceuticals Incorporated — Earnings Estimates

$477.36 USD

$4.27 (0.9%)

Volume
1.25M
Average Volume
1.52M
Market Capitalization
$121.16B
P/E Ratio
28.06
Dividend Yield
0.00%
Price Target
$576.00
Year High
$533.67
Year Low
$362.50
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$3.02

Annual earnings financials

VRTX financial data with annual/quarterly toggle

VRTX GAAP EPS - Annual & Quarterly

VRTX Sales Revenue - Annual & Quarterly

VRTX Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

VRTX Estimated and Actual Revenue by Quarter
VRTX Estimated and Actual EPS by Quarter
VRTX Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 6 1.43B 1.47B 1.45B 1.36B 1.4B 1.38B
2028-09-30 5 1.36B 1.4B 1.38B 1.29B 1.33B 1.31B
2028-06-30 5 1.31B 1.35B 1.33B 1.25B 1.29B 1.27B
2028-03-31 6 1.28B 1.32B 1.3B 1.22B 1.25B 1.23B
2027-12-31 6 1.35B 1.39B 1.37B 1.28B 1.32B 1.3B
2027-09-30 6 1.3B 1.34B 1.32B 1.24B 1.27B 1.25B
VRTX Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 6 - - - 485.81M 500.12M 492.47M
2028-09-30 5 - - - 461.71M 475.31M 468.04M
2028-06-30 5 - - - 446.48M 459.64M 452.6M
2028-03-31 6 - - - 434.35M 447.15M 440.3M
2027-12-31 6 1.47B 1.53B 1.5B 458.4M 471.9M 464.68M
2027-09-30 6 1.37B 1.42B 1.4B 441.75M 454.76M 447.8M
VRTX Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 6 3.98B 4.1B 4.04B 5 0 0 0
2028-09-30 5 3.78B 3.9B 3.84B 5 0 0 0
2028-06-30 5 3.66B 3.77B 3.71B 5 0 0 0
2028-03-31 6 3.56B 3.67B 3.61B 5 0 0 0
2027-12-31 6 3.76B 3.87B 3.81B 4 5.73326 5.95374 5.8358
2027-09-30 6 3.62B 3.73B 3.67B 4 5.35007 5.55582 5.44576